Cargando…
A Framework for a Health Economic Evaluation Model for Patients with Sickle Cell Disease to Estimate the Value of New Treatments in the United States of America
BACKGROUND: Sickle cell disease (SCD) is an inherited blood disorder associated with lifelong morbidity and increased risk of mortality that affects approximately 100,000 individuals in the United States (US), primarily of African–American descent. Due to these complications, individuals with SCD ty...
Autores principales: | Winn, Aaron, Basu, Anirban, Ramsey, Scott D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043085/ https://www.ncbi.nlm.nih.gov/pubmed/36773220 http://dx.doi.org/10.1007/s41669-023-00390-6 |
Ejemplares similares
-
Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease
por: Johnson, Kate M., et al.
Publicado: (2022) -
Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance
por: Johnson, Kate M., et al.
Publicado: (2022) -
THE ECONOMIC VALUE OF FAMILY CAREGIVING: NEW NATIONAL ESTIMATES AND STATE VARIATION
por: Houser, Ari, et al.
Publicado: (2019) -
Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries
por: Jiao, Boshen, et al.
Publicado: (2023) -
A framework for assessing the lifetime economic burden of congenital cytomegalovirus in the United States
por: Lucas, Aaron, et al.
Publicado: (2019)